close-icon

MHQ: Clinical IntelligencePowered by SurvivorNet

  • health-panel

    Medical History

  • clinical-trial

    Clinical Trials

    ?
Prefer to talk instead of typing?
close-icon

Answers offered are informational and do not constitute medical advice. Learn more

close-icon
Medical History

Review your patient’s information.

What is your gender?

What is your age?

close-icon
Clinical Trials

clinical-icon

filter

Clear List

Ask me anything about your health...

I’m listening

thinking

responding

close-icon close-icon
close-icon
close-icon
close-icon
left-icon Back to Results

Dr. Kelly Stratton

location-icon

Oklahoma City, OK

LOCATION OF PRACTICE
Integris Health Ponca City Hospital
MEDICAL Specialty:

Metastatic Respiratory System Cancer, Prostate Cancer, Urinary Tract Cancer



800 NE 10TH, SUITE 4300, OKLAHOMA CITY, OK, 73104
920 STANTON L. YOUNG BLVD, WP 3150, OKLAHOMA CITY, OK, 73104
405-271-4088
NPI Number
1154525640
ABOUT

Kelly Stratton, MD, is a Medical Oncologist in Oklahoma City, OK. He has 18 years of experience and specializes in treating conditions such as Prostate Cancer and Metastatic Respiratory System Cancer. Stratton graduated from the University of Oklahoma Health Sciences Center and is affiliated with INTEGRIS Health Ponca City Hospital and OU Health University of Oklahoma Medical Center.

Dr. Kelly Stratton profile image

Published Articles

Immunotherapy-Based Therapies in Pediatric Hodgkin Lymphoma: Potential to Narrow the Gap in Long-Term Survival.- 2026 Oct 1
Male survivors of childhood cancer and perceptions of sexual dysfunction risk: A report from the Childhood Cancer Survivor Study.- 2026 Sep 15
Deciphering taxon-specific metabolic shifts during pathogenic fungal infection in leaf-cutter ant fungal gardens.- 2026 Jan
Management of Inflammatory Myofibroblastic Tumor of Urinary Bladder With Partial Cystectomy: A Case Report.- 2026 Jun
Coordinated expansion of CD163(+) monocytes and immature CD177(+) neutrophils marks severe neurotoxicity after CD19 CAR T cell therapy.- 2026 Jul 9
Continental-scale integration of soil metagenomes and organic matter chemistry reveals ubiquitous microbial capacity for chemically-recalcitrant carbon decomposition.- 2026 Jun 15
Integrated proteogenomic and metabolomic profiling of acute myeloid leukemias to identify molecular subtypes and associated therapy targets.- 2026 Jun
Modeling long-term mortality and morbidity in pediatric Hodgkin lymphoma survivors after reduced radiotherapy exposure.- 2026 Jun 12
Aggregation Methods for Quantifying PTM and Structural Changes in Bottom-Up Proteomics.- 2026 Jun 5
OmicsMLMentor: A Web Application for Guided Machine Learning Analysis of Omics Data.- 2026 Jun 5

Clinical Trials

Combining Immunotherapy and Radiation Therapy to Help Patients Avoid Bladder Removal After Treatment Shrinks Muscle Invasive Bladder Cancer, BRIGHT Trial
Sipuleucel-T Based Autologous Cellular Immunotherapy for Advanced Prostate Cancer
Carboplatin Chemotherapy Before Surgery for People With High-Risk Prostate Cancer and an Inherited BRCA1 or BRCA2 Gene Mutation
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
Testing the Addition of an Anti-Cancer Drug, Gemcitabine, to Usual Treatment (BCG Alone) in People Whose Non-Muscle Invasive Bladder Cancer (NMIBC) Came Back After Prior BCG Therapy
Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps
Relugolix + Enzalutamide Study in High-Risk Prostate Cancer
Avelumab Plus Bacille Calmette-Guerin (BCG) in Patients With Non-muscle Invasive Bladder Cancer
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients Receiving the Usual Chemotherapy Treatment for Bladder Cancer, ARCHER Study

Other Specialists treating Metastatic Respiratory System Cancer, Prostate Cancer, Urinary Tract Cancer in Oklahoma City, OK

See All Doctors

Dr. Brian Geister

Specialty: Breast Lump, Metastatic Respiratory System Cancer, Bone Cancer

My Resources
location-icon

INTEGRIS Health Baptist Medical Center

My Resources

Dr. Sanjay Patel

Specialty: Urinary Tract Cancer, Bladder Cancer, Retroperitoneum Cancer

My Resources
location-icon

Chesapeake Regional Medical Center

My Resources

Dr. Michael Cookson

Specialty: Prostate Cancer, Urinary Tract Cancer, Retroperitoneum Cancer

My Resources
location-icon

O U Health University of Oklahoma Medical Center

My Resources

Dr. Jonathan Heinlen

Specialty: Ovarian Cancer, Kidney Cancer, Urinary Tract Cancer

My Resources
location-icon

O U Health University of Oklahoma Medical Center

My Resources

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider